Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement

The Korean Endocrine Society (KES) published clinical practice guidelines for the treatment of acromegaly in 2011. Since then, the number of acromegaly cases, publications on studies addressing medical treatment of acromegaly, and demands for improvements in insurance coverage have been dramatically...

Full description

Bibliographic Details
Main Authors: Sang Ouk Chin, Cheol Ryong Ku, Byung Joon Kim, Sung-Woon Kim, Kyeong Hye Park, Kee Ho Song, Seungjoon Oh, Hyun Koo Yoon, Eun Jig Lee, Jung Min Lee, Jung Soo Lim, Jung Hee Kim, Kwang Joon Kim, Heung Yong Jin, Dae Jung Kim, Kyung Ae Lee, Seong-Su Moon, Dong Jun Lim, Dong Yeob Shin, Se Hwa Kim, Min Jeong Kwon, Ha Young Kim, Jin Hwa Kim, Dong Sun Kim, Chong Hwa Kim
Format: Article
Language:English
Published: Academya Publishing Co. 2019-03-01
Series:Endocrinology and Metabolism
Subjects:
Acromegaly
Somatostatin analogues
Octreotide
Lanreotide
Pasireotide
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-34-53.pdf

Internet

https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-34-53.pdf

Similar Items